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1. Trypsin digestion of human serum transferrin partially saturated with iron(III)-
nitrilotriacetate at pH5.5 or pH 8.5 produces a carbohydrate-containing iron-binding
fragment of mol.wt. 43000. 2. When iron(III) citrate, FeCI3, iron(II) ascorbate and
(NH4)2SO4,FeSO4 are used as iron donors to saturate the protein partially, at pH 8.5,
proteolytic digestion yields a fragment of mol.wt. 36000 that lacks carbohydrate.
3. The two fragments differ in their antigenic structures, amino acid compositions and
peptide 'maps'. 4. The fragment with mol.wt. 36000 was assigned to the N-terminal region
of the protein and the other to the C-terminal region. 5. The distribution of iron in human
serum transferrin partially saturated with various iron donors was examined by
electrophoresis in urea/polyacrylamide gels and the two possible monoferric forms were
unequivocally identified. 6. The site designated A on human serum transferrin [Harris
(1977) Biochemistry 16, 560-564] was assigned to the C-terminal region of the protein
and the B site to the N-terminal region. 7. The distribution of iron on transferrin in
human plasma was determined.
Studies on the relative affinities of the two
metal-binding sites of transferrins for iron have
produced many conflicting results that are often
further confused, unnecessarily, by the lack of
clarification of the source and species.
For human serum transferrin, equilibrium dialysis
indicated that there was sequential occupancy of the
sites (K1 = 400K2, where K1 is the association constant
for iron at the first site and K2 that for the second site)
(Davis et al., 1962), although with the same technique
Aasa et al. (1963) concluded that the sites were
equivalent and independent. It was thought that in
the first determination true equilibrium was never
attained.
A moving-boundary-electrophoretic study (Aisen
et al., 1966) in which (NH4)2SO4,FeSO4 was added
to human serum transferrin at pH 6.7 showed that the
protein can be separated into three species, with 0, 1
and 2 atoms of iron. The distribution of iron was
thought to support the theory of random iron
binding, but on careful re-examination the results
suggest a sequential binding process. Gel isoelectric
focusing also resolves three forms of transferrin
(Hovanessian & Awdeh, 1976); however, the distri-
bution of iron, when added as iron(Ill)-nitrilotri-
acetate to the protein in 1 mM-NaHCO3, agrees well
with that predicted for equivalent sites. Both these
electrophoretic methods fail to resolve the two
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possible monoferric forms of the protein, presumably
because they have the same isoelectric point, as
with the two monoferric species of hen ovotransferrin
(Williams, 1975). However, polyacrylamide-gel elec-
trophoresis in the presence of 6M-urea (Makey &
Seal, 1976) will resolve iron-free human serum
transferrin, the two monoferric transferrins and fully
saturated transferrin. Until now this technique has
not been used to study in detail the distribution of iron
when added to the iron-free protein.
Lane (1975) has shown that it is possible to separate
two monoferric forms of human serum transferrin
by chromatography on DEAE-cellulose at pH 7.9.
From the distribution of iron in samples of protein
that had been partially saturated with FeCl3 at pH 5.0
and subsequently raised to pH 7.9 he concluded that
binding had taken place randomly.
In spite of the results supporting the equivalence
of the sites, other workers have now shown that the
two sites exhibit different pH-dependencies. One site
retains its iron down to about pH 5, whereas the other
loses its iron around pH6 (Princiotto & Zapolski,
1975; Lestas, 1976). The site that retains its iron at
low pH, designated the A site, has also been shown to
bind iron preferentially at pH 7.5 when iron(III)-
nitrilotriacetate is used as the iron donor (Harris,
1977a).
In view of the conflicting reports on the binding of
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iron to human serum transferrin we set out to
examine the way in which various iron donors occupy
the iron-binding sites on the protein. We have used
a method, first reported by Williams (1974), for the
isolation of the N-terminal fragment of hen ovo-
transferrin, which involves partial iron saturation of
the protein, proteolytic digestion of unoccupied
binding sites and identification of the iron-binding
fragments remaining. We have then exploited the
observed differences in the order of binding of
different iron donors to isolate and characterize the
two iron-binding domains. With the electrophoretic
method of Makey & Seal (1976) we have been able to
compare the distribution of iron when added to
transferrin in different forms and under different
conditions and then been able to identify the mono-
ferric form of transferrin present in normal blood.
Materials and Methods
Preparation ofhuman serum transferrin
Human serum transferrin was prepared by a
modification ofthe method ofRoop & Putnam (1967)
starting with Cohn IV fraction (Cohn et al., 1946)
from outdated pooled human plasma. First 3 litres
of Cohn IV fraction was dialysed twice for 12h at
4°C against 10 litres of phosphate-buffered saline
(Dulbecco & Vogt, 1954) and the precipitate removed
by centrifugation at 6000g for 1 h at 4°C. Iron(III)-
nitriloacetate and NaHCO3 were added to the
supernatant to final concentrations of 0.2 and 0.5 mm
respectively to saturate the transferrin and the
solution was then dialysed twice for 6h at 4°C
against water adjusted to pH9.4 with aq. NH3.
An equal volume of 0.6% (w/v) rivanol (2-ethoxy-
acridine-6,9-diamine lactate monohydrate) in 5mM-
Tris/HCl, pH9.4, was added dropwise overnight at
4°C to the stirred solution. The precipitate that formed
was removed by centrifugation at 6000g for I h
at 4°C and the supernatant filtered through a pad of
potato starch (BDH Chemicals, Poole, Dorset, U.K.),
previously washed with 5 mM-Tris/HCI, pH 9.4,
to remove the rivanol. Then 1.5 litres of a slurry of
DEAE-Sephadex A-50 equilibrated in 5 mM-Tris/HCI,
pH8.8, was added to the filtrate, and after standing
for 2h at 20°C the suspension was filtered through a
Buchner funnel. The ion-exchange resin was washed
with buffer until the eluate was protein-free and then
the bound transferrin was eluted with 0.1 M-NaCl.
After dialysis of the eluate overnight against 10 litres
of 50mM-Tris/HCI, pH 8.8, the protein was adsorbed
on a column (12cmx 30cm) of DEAE-Sephadex
A-50, in the same buffer, which was washed with
buffer until the eluate was free of protein as indicated
by A280. The transferrin was eluted with 0.1 M-NaCl,
dialysed against water and freeze-dried. The yield
of protein was 20g.
Iron-free transferrin
Iron was removed from transferrin by the method
of Warner & Weber (1951) by using the anion-
exchange resin Bio-Rad AGI (X2, 200-400 mesh,
Cl- form) (Bio-Rad Laboratories, Richmond, CA,
U.S.A.). The protein was shown to be iron-free by the
lack of the characteristic absorption band of iron-
transferrin at 470nm [A470 = 5 x 103M-1 - cm-l (Aasa
et al., 1963)].
Polyacrylamide-gel electrophoresis
Samples for sodium dodecyl sulphate/polyacryl-
amide-gel electrophoresis were dissolved in a buffer
containing 5% (w/v) sodium dodecyl sulphate, 10%
(v/v) glycerol, 1 % 2-mercaptoethanol, 0.01 % Bromo-
phenol Blue and 5mM-sodium phosphate, pH 7.0,
and heated for 3 min in a boiling-water bath. When
unreduced samples were required the 2-mercapto-
ethanol was omitted.
Electrophoresis was carried out on gels contain-
ing 7.5% (w/v) acrylamide and 0.2% (w/v) NN'-
methylenebisacrylamide in 0.1 % sodium dodecyl
sulphate and 0.05M-sodium phosphate, pH 7.0.
Gels were stained for protein with Coomassie
Brilliant Blue R-250 by the method of Berg (1969)
and for carbohydrate with the periodic acid/
Schiff's-base stain (Zacharias et al., 1969). Molecular
weights were determined by the use of a marker
mixture that contained ovotransferrin (mol.wt.
80000), bovine serum albumin (mol.wt. 67000),
lactate dehydrogenase (subunit mol.wt. 36000) and
horse heart cytochrome c (mol.wt. 12400).
Polyacrylamide-gel electrophoresis in 6M-urea
was carried out by a modification of the method of
Makey & Seal (1976) as described by Williams et al.
(1978).
Before examination of transferrin in human plasma
samples the plasma was treated by the method of
Matson et al. (1966). To 0.1 ml of plasma was added
0.3 ml of reservoir buffer and 0.5 ml of 0.6% (w/v)
rivanol in reservoir buffer, and the precipitate
removed by centrifugation (lOOOg for 5min). This
procedure removes all plasma proteins except the
fi- and y-globulins and simplifies the gel pattern.
Starch-gel electrophoresis
Flat-bed starch-gel electrophoresis was carried
out in 13% (w/v) gels in the discontinuous buffer
system of Poulik (1957). Protein was stained with I %
(w/v) Naphthalene Black (12B) in methanol/acetic
acid/water (5:1:5, by vol.) and destained by washing
in the same solvent.
Preparation of iron chelates
Iron(III)-nitrilotriacetate and iron(II) ascorbate
were prepared by the method of Woodworth (1966).
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Iron(III) citrate was prepared with an iron/citrate
molar ratio of 1:20. Under these conditions the
predominant species in solution is thought to be
iron(III) dicitrate (Spiro et al., 1967).
Immunological methods
An antiserum tohuman serum transferrin was raised
in a sheep. Antigen-antibody reactions were observed
by the Ouchterlony (1958) method with undiluted anti-
sera. Antigen solutions were either prepared by
dissolving protein (1 mg/ml) in 0.1 M-sodium phos-
phate, pH 7.0, or taken directly from column fractions.
Peptide 'maps'
Protein was taken up in 5% (v/v) formic acid and
digested with pepsin (from pig stomach mucosa;
Sigma Chemical Co., St. Louis, MO, U.S.A.) at an
enzyme/substrate ratio of 1: 30 (w/w) for 15 h at 37°C.
One-dimensional electrophoretic patterns were run
at pH6.5 and 3.5. A sample (25nmol) of each digest
was applied directly to 2.54cm (1 in) of starting line
on Whatman 3MM paper and electrophoresis was
carried out for I h at 60V/cm. Peptides were stained
with the cadmium acetate/ninhydrin reagent of
Heilmann et al. (1957) and in addition tyrosine- and
tryptophan-containing peptides were detected by the
specific stains of Jepson & Smith (1953).
Amino acid analysis
Protein samples were hydrolysed at 105°C with
5.7M-HCl in sealed evacuated tubes, after flushing
several times with N2, for 24h and analysed on a
Rank Hilger Chromaspek J180 instrument.
Preparation ofhuman serum transferrin partially iron
saturated at pH8.5
Samples of human serum transferrin in 0.1 M-
NaHCO3, pH 8.5, partially saturated with iron(III)-
nitrilotriacetate, iron(II) ascorbate or (NH4)2SO4,-
FeSO4 were prepared by addition of the calculated
amount of iron donor after titration of the iron.,free
protein by monitoring the change in A470. As the
uptake of iron by transferrin is a slow process when
iron(III) citrate and FeCI3 are used as iron donors
(Bates et al., 1967; Bates & Schlabach, 1973) samples
of protein partially saturated by them were obtained
by addition of an amount based on the values for the
other iron chelates. In all cases the partially iron-
saturated samples were left for 15 h at 4°C to ensure a
quantitative binding of the iron, which was confirmed
by measurements of A470-
Preparation ofhuman serum transferrin partially iron-
saturated with iron(III)-nitrilotriacetate atpH5.5
Iron-free protein (300mg) in 0ml of 0.1 M-Hepes
[4 - (2 - hydroxyethyl) - 1 - piperazine - ethanesulphonic
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acid]/0.01M-NaHCO3, pH5.5, was 40%-iron-satur-
ated with iron(lII)-nitrilotriacetate, as judged by
A470. After standing at 20°C for 45min the solution
was passed through a column (1cmx 10cm) of
Bio-Rad AG 1-X2, which had been previously
equilibrated with the same buffer, to remove any
unbound iron. The pH was then adjusted to 7.45 by
addition of 0.1 M-NaOH.
Digestion of partially iron-saturated human serum
transferrin
Partially iron-saturated samples of protein (50mg/
ml) were digested with trypsin (bovine trypsin type XI
treated with diphenylcarbamoyl chloride; Sigma)
for 6h at 37°C at an enzyme/protein ratio of 1:30
(w/w), followed by a second addition of the same
amount of enzyme and incubation for a further 15 h.
To check that this procedure digested away all iron-
free sites a sample of iron-free protein was treated
in the same way and shown to be unable to bind iron.
Results
Susceptibility of iron-free and iron-saturated human
serum transferrin to proteolytic digestion
Treatment of iron-free transferrin with trypsin at
pH 8.5 results in complete loss of its iron-binding
ability, and sodium dodecyl sulphate/polyacrylamide-
gel electrophoresis reveals that the protein has been
digested to low-molecular-weight peptides. Under
the same conditions the fully-saturated protein
retains its bound iron, as judged by its A470, and
moves as a single band of mol.wt. 80000 on sodium
dodecyl sulphate/polyacrylamide gels. However,
when the fully saturated/protein was examined by
sodium dodecyl sulphate-polyacrylamide-gel electro-
phoresis in the presence of 2-mercaptoethanol,
several bands were observed, suggesting that the
protein had undergone some internal cleavage but
was still held together by disulphide bridges. This
suggestion is confirmed by starch-gel electrophoresis,
which can detect charge heterogeneity in a given
protein. Untreated iron-saturated transferrin moves
as a single band on starch gel, but after treatment with
trypsin it gives multiple bands that move faster than
the native protein. The effect of trypsin on fully
saturated human serum transferrin is different from
that reported by Brock et al. (1976) on fully
saturated bovine serum transferrin. The bovine
protein is cleaved into separate iron-binding domains.
Proteolytic digestion of human serum transferrin
partially iron-saturated atpH 8.5
Samples of transferrin that had been 30%-iron-
saturated, at pH8.5, with four different iron donors,
iron(III)-nitrilotriacetate, FeCl3, iron(II) ascorbate
and (NH4)2SO4,FeSO4, were treated with trypsin
S
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Fig. 1. Sodium dodecyl sulphate/polyacrylamide-gel electrophoresis of trypsin digests of 30%-iron-saturated human
serum transferrin
Samples of iron-free human serum transferrin in 0.1 M-NaHCO3, pH8.5, were 30%'-iron-saturated with iron(III)-
nitrilotriacetate, FeCl3, iron(ll) ascorbate and (NH4)2SO4,/FeSO4 and digested with trypsin, as described in the
Materials and Methods section. Gels 1-6 were run in the absence of 2-mercaptoethanol and gels 7-12 were run in
the presence of 2-mercaptoethanol. Gels 1 and 7 are a marker mixture containing hen ovotransferrin (mol.wt. 80000),
bovine serum albumin (mol.wt. 67000), lactate dehydrogenase (mol.wt. 36000) and cytochrome c (mol.wt. 12400).
Gels 2 and 8 are samples of transferrin labelled with iron(III)-nitrilotriacetate. Gels 3 and 9 are samples labelled
with FeCl3. Gels 4 and 10 are samples labelled with iron(lI) ascorbate. Gels 5 and 11 are samples labelled with
(NH4)2SO4,FeSO4. Gels 6 and 12 are samples of undigested transferrin.
to digest away unoccupied iron-binding sites. The
sodium dodecyl sulphate/polyacrylamide-gel-electro-
phoretic pattern, in both the presence and the
absence of reducing agent, is shown in Fig. 1. As can
be seen from the unreduced samples (gels 2-5), the
gel pattern of the sample partially saturated by
using iron(III)-nitrilotriacetate shows two main
species with mol.wts. 80000 and 43000, whereas
the three other samples have only a trace of the
second species but two components with mol.wts.
33 500 and 36000. In the presence of reducing agent
(Fig. 1, gels 8-11) the gel-electrophoretic pattern of
the iron(III)-nitrilotriacetate sample is again different
from the other three; however, the interpretation is
complicated by the fact that none of the main species
observed in the absence of reducing agent are single
chains. As the fully saturated protein has been shown
to undergo limited proteolytic cleavage, it is not
surprising that the fragments do not have a single-
chain structure.
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Fig. 2. Gel-filtration patterns on Sephade.
135cm) in 0.02M-NH4HCO3 of trypsin
serum transferrin partially iron sature
(a) Protein partially iron-saturated
iron(II) ascorbate or (NH4)2S04,FeS(
partially iron-saturated with iron
acetate. Fractions of volume 2.35 ml i
C Immunological properties of the fragments from thedigests
Whenexamined by the Ouchterlonymethod against
an antiserum to whole human serum transferrin,
each of the fragments from the samples partially
c saturated with FeCl3, iron(III) citrate, iron(II)
C ascorbate and (NH4)2SO4,FeSO4 gave precipitin
lines that fused with each other but showed only
partial identity with that of the whole protein.
The fragment of mol.wt. 43000 from the sample
60 80 partially saturated with iron(III)-nitrilotriacetate
also showed partial identity with transferrin, but its
x G-100 (1.2cmx precipitin line crossed those from the other four
digests of human samples, suggesting a complete lack of common
ated at pH8.5 antigenic determinants. This is illustrated in Fig. 3(a).
with FeCl3, The precipitin line produced by a mixture of the two
04; (b) protein types of fragment fuses with that produced by the
(Il)-nitrilotri- whole protein (Fig. 3b), so together the fragments
were collected. appear to account for all the determinants on
transferrin.
In a separate experiment two samples of transferrin
were partially saturated with iron(III) citrate and
iron(III)-nitrilotriacetate and digested with trypsin,
as in the above experiment. Gel electrophoresis
showed that the sample labelled with iron(III)
citrate gives rise to the same components as FeCl3,
iron(II) ascorbate and (NH4)2SO4,FeSO4.
When unreduced gels were stained for carbohydrate
only the species with mol.wts. 80000 and 43 000 were
found to be carbohydrate-positive.
Gel filtration of each digest was carried out on
Sephadex G-100. The samples that had been
partially saturated with FeCI3, iron(II) ascorbate,
(NH4)2SO4,FeSO4 and iron(III) citrate were resolved
into two protein peaks, A and B (Fig. 2a), both pink in
colour, followed by low-molecular-weight peptides
(peak C). Sodium dodecyl sulphate/polyacrylamide-
gel electrophoresis showed that peak A had a
mol.wt. of 80000 and peak B had two components
with mol.wts. 33500 and 36000 corresponding to
those observed on gel electrophoresis of the whole
digests (Fig. 1, gels 3-5). Gel filtration of the sample
that had been partially saturated with iron(III)-
nitrilotriacetate failed to resolve the protein com-
ponents completely and the fragment with mol.wt.
43000 appeared as a shoulder on the main peak
(Fig. 2b, peak A/B), the position of which was shifted
to a slightly higher elution volume relative to peak A
in the other samples. In spite of this poor resolution,
a sample of the 43000-mol.wt. fragment with only a
slight contamination by the other component was
obtained by taking a narrow cut from the fractions on
the shoulder. We will show below that the 43000-
mol.wt. fragment can be resolved on Sephadex G-200.
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Proteolytic digestion of human serum transferrin
partially saturated with iron(III)-nitrilotriacetate at
pH5.5
A sample of transferrin that had been 30%-iron-
saturated with iron(III)-nitrilotriacetate at pH5.5,
passed down a cation-exchange resin to remove any
unbound iron and digested with trypsin after the pH
of the solution had been raised to 7.45 produced the
same gel-filtration pattern on Sephadex G-100 as the
sample of protein that had been partially saturated
with the same iron chelate at pH8.5.
Gel filtration of digests of partially iron-saturated
human serum transferrin on Sephadex G-200
The fragment derived from digestion of transferrin
partially iron-saturated with iron(III)-nitrilotriacet-
ate at either pH 5.5 or 8.5 is not fully resolved from the
whole protein by gel filtration on Sephadex G-100
(Fig. 2b); however, gel filtration on Sephadex G-200
separated the two proteins (Fig. 4a). Peaks A and B
both contain carbohydrate, as revealed by the
orcinol/H2SO4 test (Winzler, 1955), and both bind
iron, asjudged by the A470. Sodium dodecyl sulphate/
polyacrylamide-gel electrophoresis confirmed that
peak A was whole protein that had undergone limited
proteolytic cleavage and peak B contained the
fragment of mol.wt. 43 000. Peaks C and D
represent low-molecular-weight glycopeptides and
peptides. Whereas peaks A and B have similar
A280/A470 ratios, peak B contains relatively more
carbohydrate than peak A.
For comparison, gel filtration on Sephadex G-200
of a tryptic digest of transferrin partially iron-
saturated with (NH4)2SO4,FeSO4 at pH 8.5 is
shown in Fig. 4(b). Again two protein peaks, A and B,
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Fig. 4. Gel-filtration patterns on Sephadex G-200 (2.4cm x
120cm) in 0.1 M-NH4HCO3 oftrypsin digests ofpartially
iron-saturated human transferrin
(a) Human serum transferrin partially iron-saturated
with iron(III)-nitrilotriacetate at pH8.5; (b) human
serum transferrin partially iron-saturated with
(NH4)2S04,FeSO4 at pH 8.5. , A280; -,
A470; - -, A540 in the orcinol assay. For details of
peaks A-D see the text. Fractions of volume 6.8ml
were collected.
Fig. 3. Agar-gel diffusion plate
(a) Wells 1, 2 and 3 contained human serum
transferrin, the fragment of mol.wt. 36000 and the
fragment of mol.wt. 43000 respectively. The central
well contained antiserum to human serum transferrin.
(b) Well I contained human serum transferrin. Well 2
contained a mixture of equal amounts of the two
fragments. Wells 3 and 4 contained the fragment of
mol.wt. 36000 and the fragment of mol.wt. 43000
respectively. The central well contained antiserum to
human serum transferrin.
phoresis showed that peak B represented a fragment
of mol.wt. 36000.
During the isolation procedure for human serum
transferrin the protein loses some of its bound iron
and the final preparation is about 40% iron-
saturated. On trypsin digestion the protein yields the
fragment of mol.wt. 43000.
Amino acid composition of the fragments
The amino acid compositions of human serum
transferrin, the fragment of mol.wt. 36000 and the
fragment of mol.wt. 43000, as isolated by gel
filtration on Sephadex G-200 are given in Table 1.
The fragments have similar compositions, although
differences are apparent in their contents of aspartic
acid, glutamic acid, threonine and phenylalanine.
The sum of the compositions of the fragments agrees
reasonably well with that of the whole protein.
Carbohydrate composition of the fragments
The hexose content of the 36000- and 43000-
mol.wt. fragments, as determined by the orcinol/
H2SO4 test, were found to be 1.9 and 10.1 mol of
sugar/mol of protein respectively. Jamieson (1965)
showed that human serum transferrin has two
carbohydrate groups of identical composition, each
1978
are found; however, although they both contain
iron, peak B is essentially free of carbohydrate.
Sodium dodecyl sulphate/polyacrylamide-gel electro-
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mino acid composition of human serum
transferrin and offragments
e expressed as mol of amino acid/mol
43000-
mol.wt.
fragment
34.7
16.8
17.8
32.9
16.4
31.0
33.8
16.8
17.8
4.5
9.2
34.8
14.2
13.8
10.1
35.5
13.5
Sum of
fragments
61.9
27.2
36.8
58.2
35.9
59.1
69.8
31.4
36.6
8.2
17.6
67.5
27.6
32.2
19.9
67.0
25.9
Human
serum
transferrin
62.5
24.0
33.3
54.8
32.8
56.5
63.4
36.8
38.8
9.6
17.8
66.5
31.5
31.8
18.6
59.6
26.9
containing 2 sialic acid residues, 8 N-acetylglucos-
amine groups, 4 mannose residues and 2 galactose
residues. This was confirmed by Graham & Williams
(1975) in their work on the amino acid sequence of
glycopeptides from a number oftransferrins, although
their carbohydrate analyses indicated that each carbo-
hydrate group contained 3 residues of both mannose
and galactose. In the present work no attempt was
made to determine the relative amounts of galactose
and mannose in each fragment; however, the hexose,
contents that we obtained indicate that both
carbohydrate groups lie within the fragment of
mol.wt. 43000.
As the two carbohydrate groups will contribute
about 5000 to the molecular weight of the fragment,
the difference in molecular weight between the two
fragments can be attributed mainly to the presence
of carbohydrate on the fragment derived from the
iron(III)-nitrilotriacetate-labelled protein.
Peptide 'maps'
Pepsin digests of the fragments as well as human
serum transferrin were examined by one-dimensional
electrophoresis at pH3.5 and 6.5. When the electro-
phoretograms were stained with ninhydrin the two
fragments gave different patterns, which together
appeared to account for all the bands in the trans-
ferrin digest. The ninhydrin-stained electrophoreto-
gram, which was run at pH6.5, is shown in Fig. 5.
Similarly, when the specific stains for tryptophan
and tyrosine were used the fragments gave different
patterns, which when combined again accounted
for the bands in the digest of the whole protein.
Vol. 173
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Fig. 5. One-dimensional electrophoretogram at pH6.5 of
pepsin digests of(a)fragment ofmol.:wt. 36000, (b)fragment
ofmol.wt. 43000 and(c) human serum transferrin
The electrophoretogram was stained with the
cadmium acetate/ninhydrin reagent. For details see
the Materials and Methods section.
Absorption spectra of the fragments
Both fragments had an absorption maximum in
the region of 460-470nm, characteristic of trans-
ferrins, and A280/A470 ratios of 23.1 and 23.2 respec-
tively. For comparison fully-saturated human serum
transferrin has a value of 23.5 for the A280/A470
0Table 1. A)
Results arc
of protein.
Amino r
acid fi
Asp
Thr
Ser
Glu
Pro
Gly
AlajCys
Val
Met
Ile
Leu
Tyr
Phe
His
Lys
Arg
36000-
mol.wt.
Iragment
27.2
10.4
19.0
26.3
19.5
28.1
36.0
14.6
18.8
3.7
8.4
32.9
13.4
18.4
9.8
31.5
12.4 Origin
(a) (b) (c)
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Fig. 6. Urealpolyacrylamide-gel electrophoresis ofhuman serum transferrin partially iron-saturated with various iron donors
atpH6.0 and 8.5
Samples (a) (25,ug) and (n) (25,ug) are partially iron-saturated preparation of human serum transferrin. Samples (b)
(25 pg) and (c) (50 pg) are proteins partially iron-saturated with iron(III)-nitrilotriacetate at pH 8.5. Samples (d) (25pg)
and (e) (50g) are proteins partially iron-saturated with (NH4)2SO4,FeSO4 at pH8.5. Samples (f) (25/,g) and (g)
(50ug) are proteins partially iron-saturated with FeCJ3 at pH8.5. Samples (h) (25pg) and (i) (50,ug) are proteins
partially iron-saturated with iron(III)-nitrilotriacetate at pH 6.0. Samples (j) (25pg) and (k) (50g) are proteins partially
iron-saturated with (NH4)2SO4,/FeSO4 at pH6.0. Samples (I) (25,ug) and (m) (50,ug) are proteins partially
iron-saturated with FeCl3 at pH6.0. HST indicates the position on the gel of iron-free human serum transferrin,
HST-Fe the position of monoferric transferrin with iron in the C-terminal site, Fe-HST the position of monoferric
transferrin with iron in the N-terminal site and Fe2HST the position of fully saturated transferrin.
ratio. A slight difference in the absorption maxima
was observed for the fragments, but as yet it is not
known whether this is of any significance.
Reversibility of iron binding to fragments
Both the iron-free fragments were titrated with
iron(III)-nitrilotriacetate and (NH4)2SO4,FeSO4 at
pH 8.5; however, only the fragment of mol.wt. 43 000
took up its original complement of iron, as indicated
by the A470. The lower-molecular-weight fragment
would only take up about 30% of the theoretical
amount of iron, irrespective of the nature of the
iron donor.
Urealpolyacrylamide-gel electrophoresis of partially
iron-saturated human serum transferrin and human
plasma
Human serum transferrin can be separated into
four species, namely iron-free protein, two monoferric
species and fully iron-saturated protein, by electro-
phoresis at pH 8.4 in polyacrylamide gels containing
6M-urea (Makey & Seal, 1976). As shown in Fig. 6
addition of iron as iron(III)-nitrilotriacetate (samples
b and c) to iron-free transferrin, at pH 8.5, enhances
the slower-migrating of the two intermediate forms,
whereas when (NH4)2SO4,FeSO4 (samples d and e)
and FeCl3 (samples f and g) are used as iron donors
the faster-moving intermediate band is preferentially
formed.
When samples of transferrin in 0.1 M-Hepes/
0.01 M-NaHCO3, pH 6.0, were partially saturated
with the same three iron donors electrophoresis in
urea/polyacrylamide gels (Fig. 6, samples h-m)
revealed that in all three cases only the apoprotein
and the slower of the two intermediates were present.
The isolation procedure for human serum trans-
ferrin yields protein that is about 40% iron-
saturated and that on digestion with trypsin it gives
rise to the fragment with mol.wt. 43000. Urea/
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polyacrylamide-gel electrophoresis of this partially
saturated protein (Fig. 6, samples a and n) showed
that it contained mainly the slower-running mono-
ferric species, together with small amounts of
iron-free and iron-saturated transferrin.
Plasma from normal subjects was examined by this
gel-electrophoresis method and found to contain
only iron-free protein and the first intermediate.
To check that the second intermediate can exist in
plasma, iron(III)-nitrilotriacetate and (NH4)2SO4,-
FeSO4 were used to saturate the transferrin partially
in plasma from iron-deficient patients. It was
observed that, as with the pure protein, iron(III)-
nitrilotriacetate enhances the slower-migrating inter-
mediate band, whereas the other iron donor enhances
the faster-migrating intermediate.
Discussion
In the present paper we have shown that proteo-
lytic digestion of partially iron-saturated human
serum transferrin gives rise to iron-binding frag-
ments. Under the same conditions the iron-free
protein is completely degraded to low-molecular-
weight peptides, whereas the iron-saturated protein
undergoes some internal cleavage but retains its
complement of iron, and under non-reducing con-
ditions has the same mobility on sodium dodecyl
sulphate/polyacrylamide-gel electrophoresis as the
native protein. Similar observations have been made
with hen ovotransferrin (Williams, 1974, 1975),
except that the fully saturated protein was completely
resistant to attack by trypsin. For bovine serum
transferrin Brock et al. (1976) found that trypsin
digestion of the iron-saturated protein produces
two fragments that were subsequently thought to
represent the two domains of the protein (Brock &
Arzabe, 1976).
Proteolytic digestion of human serum transferrin
saturated to 30% with iron(III)-nitrilotriacetate at
either pH5.5 or pH8.5 produces a carbohydrate-
containing fragment of mol.wt. 43000. However,
when four other iron donors, iron(III) citrate,
FeCI3, iron(II) ascorbate and (NH4)2SO4,FeSO4,
are used partially to saturate the protein at pH8.5
a different fragment is obtained after digestion with
trypsin. This second fragment lacks carbohydrate
and has mol.wt. 36000. In some experiments this
fragment was accompanied by a minor fragment of
slightly lower molecular weight, possibly owing to
further digestion. Neither the 36000-mol.wt. frag-
ment nor the 43GO0-mol.wt. fragment possesses a
single chain; however, this is not surprising in view
of the fact that the fully saturated protein itself
undergoes limited cleavage with trypsin.
Although the smaller fragment is readily separated
from undigested protein by gel filtration on
Sephadex G-100, the other fragment could only be
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completely resolved from transferrin by gel filtration
on Sephadex G-2C0. As well as differing in molecular
weight and carbohydrate composition the fragments
have different peptide 'maps' and amino acid
compositions and are immunologically distinct.
Their only similarity is in their absorption spectra,
which are almost identical and characteristic of all
transferrins. Studies on human serum transferrin
(MacGillivray et al., 1977) have shown that the two
carbohydrate groups on the protein lie within the
C-terminal half of the protein, so we conclude that
the fragment with mol.wt. 43000 must represent the
C-terminal region and the other fragment the
N-terminal region. The availability of the isolated
iron-binding domains will simplify further investi-
gations into the structural properties of the iron-
binding sites.
The observation that iron(III)-nitrilotriacetate,
a non-physiological iron donor, has a preference for
the C-terminal site at both pH 5.5 and pH 8.5 agrees
with the work of Harris (1977a), who also found that
one particular site, designated A, exhibits a tendency
to bind iron first at both acidic and neutral pH. We
now know that the A site lies in the C-terminal
region of the protein. In hen ovotransferrin the
N-terminal site preferentially binds iron, when
added as iron(III)-nitrilotriacetate, at pH8.5, but
at acidic pH the C-terminal site takes up iron
preferentially (Williams et al., 1978).
Although the other iron donors that we examined,
which showed a preference for the N-terminal site,
might be expected to resemble more closely the form
in which iron is present in the body, the distri-
bution of iron on transferrin in normal plasma
suggests that this is not so. By using a urea/
polyacrylamide gel, which resolves iron-free human
serum transferrin, the two monoferric transferrins
and fully saturated transferrin (Makey & Seal, 1976),
we have compared the pattern obtained when iron in
different forms is added to the pure protein with the
pattern in normal blood. Human plasma, where the
transferrin is about 30% iron-saturated (Giovaniello
& Peters, 1963), contains two species, iron-free
transferrin and a monoferric form that corresponds
to that obtained when iron(III)-nitrilotriacetate is
added to the isolated protein atpH 6.0 or 8.5 and there-
fore has iron in the C-terminal site. Transferrin in
the plasma of iron-deficient patients is essentially
iron-free, so it was possible to confirm that, as with
the pure protein, addition of iron(III)-nitrilotri-
acetate to plasma enhances the monoferric form with
iron in the C-terminal site, whereas the other donors
enhance the other monoferric species.
It is noteworthy that, as for hen ovotransferrin
(Williams et al., 1978), the monoferric human serum
transferrin species with iron in the C-terminal site has
a lower mobility in urea/polyacrylamide gels than the
form with iron in the N-terminal site. In the original
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report on this gel method (Makey & Seal, 1976)
the exact basis for the separation of the monoferric
transferrins was uncertain. However, now that we
know that in both hen ovotransferrin (Williams,
1975) and human serum transferrin there is an
asymmetric distribution of the carbohydrate groups
between the two halves of each protein it is tempting
to postulate that it is this difference that results in the
monoferric species having different mobilities.
For several years there have been repor.ts for and
against the hypothesis of Fletcher & Huehns (1967,
1968) that the two sites of transferrin have different
physiological roles. Most recently Harris (1 977b)
showed conclusively that iron is taken up in equal
proportions from both sites of fully saturated
human serum transferrin by human reticulocytes.
This result was taken as definitive evidence that there
is no functional difference between the sites.
However, as our results show that normal plasma
does not contain appreciable amounts of diferric
transferrin, a more correct demonstration of the
role of the two sites requires a comparative study
with the specifically labelled forms. Now that we
can prepare these by using different iron donors a
more valid test is possible.
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